Hugh Mohan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hugh Mohan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Silvia Giordani
School of Chemical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland
3 shared publications - Andrew Fagan
SSPC, Taighde Éireann - Research Ireland Centre for Pharmaceuticals, School of Pharmacy, University College Cork, Cork T12 YT20, Ireland
1 shared publication - Michał Bartkowski
School of Chemical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland
1 shared publication - Silvia Arpicco
Department of Drug Science and Technology, University of Turin, Turin, Italy
1 shared publication - Valeria Bincoletto
Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy
1 shared publication
Latest Publications
- Open Access
- 19 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1545
Carbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems
Carbon nanomaterials (CNMs) are an incredibly versatile class of materials that can be used as scaffolds to construct anticancer nanocarrier systems. The ease of chemical functionalisation, biocompatibility, and intrinsic therapeutic capabilities of many of these nanoparticles can be leveraged to design effective anticancer systems. This article is the first comprehensive review of CNM-based nanocarrier systems that incorporate approved chemotherapy drugs, and many different types of CNMs and chemotherapy agents are discussed. Almost 200 examples of these nanocarrier systems have been analysed and compiled into a database. The entries are organised by anticancer drug type, and the composition, drug loading/release metrics, and experimental results from these systems have been compiled. Our analysis reveals graphene, and particularly graphene oxide (GO), as the most frequently employed CNM, with carbon nanotubes and carbon dots following in popularity. Moreover, the database encompasses various chemotherapeutic agents, with antimicrotubule agents being the most common payload due to their compatibility with CNM surfaces. The benefits of the identified systems are discussed, and the factors affecting their efficacy are detailed.
- 19 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1545
Open AccessCarbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems
Carbon nanomaterials (CNMs) are an incredibly versatile class of materials that can be used as scaffolds to construct anticancer nanocarrier systems. The ease of chemical functionalisation, biocompatibility, and intrinsic therapeutic capabilities of many of these nanoparticles can be leveraged to design effective anticancer systems. This article is the first comprehensive review of CNM-based nanocarrier systems that incorporate approved chemotherapy drugs, and many different types of CNMs and chemotherapy agents are discussed. Almost 200 examples of these nanocarrier systems have been analysed and compiled into a database. The entries are organised by anticancer drug type, and the composition, drug loading/release metrics, and experimental results from these systems have been compiled. Our analysis reveals graphene, and particularly graphene oxide (GO), as the most frequently employed CNM, with carbon nanotubes and carbon dots following in popularity. Moreover, the database encompasses various chemotherapeutic agents, with antimicrotubule agents being the most common payload due to their compatibility with CNM surfaces. The benefits of the identified systems are discussed, and the factors affecting their efficacy are detailed.
- Open Access
Supramolecular Functionalisation of B/N Co-Doped Carbon Nano-Onions for Novel Nanocarrier Systems
Boron/nitrogen co-doped carbon nano-onions (BN-CNOs) are spherical nanoparticles that consist of multiple inter-nestled fullerene layers, giving them an onion-like internal structure. They have potential as nanocarriers due to their small size, aqueous dispersibility, and biocompatibility. The non-covalent attachment of a biocompatible polymer to BN-CNOs is a simple and effective method of creating a scaffold for a novel nanocarrier system as it allows for increased aqueous dispersibility whilst preventing the immune system from recognising the particle as a foreign object. The non-covalent approach also preserves the electronic and structural properties of the BN-CNOs. In this study, we attached a hyaluronic acid-phospholipid (HA-DMPE) conjugate polymer to the BN-CNO’s surface to improve its hydrophilicity and provide targetability toward HA-receptor overexpressing cancer cells. To this end, various ratios of HA-DMPE to BN-CNOs were investigated. The resulting supramolecular systems were characterised via UV-Vis absorption and FTIR spectroscopy, dynamic light scattering, and zeta potential techniques. It was found that the HA-DMPE conjugate polymer was permanently wrapped around the BN-CNO nanoparticle surface. Moreover, the resulting BN-CNO/HA-DMPE supramolecular systems displayed enhanced aqueous solubility compared to unfunctionalised BN-CNOs, with excellent long-term stability observed in aqueous dispersions.
Open AccessSupramolecular Functionalisation of B/N Co-Doped Carbon Nano-Onions for Novel Nanocarrier Systems
Boron/nitrogen co-doped carbon nano-onions (BN-CNOs) are spherical nanoparticles that consist of multiple inter-nestled fullerene layers, giving them an onion-like internal structure. They have potential as nanocarriers due to their small size, aqueous dispersibility, and biocompatibility. The non-covalent attachment of a biocompatible polymer to BN-CNOs is a simple and effective method of creating a scaffold for a novel nanocarrier system as it allows for increased aqueous dispersibility whilst preventing the immune system from recognising the particle as a foreign object. The non-covalent approach also preserves the electronic and structural properties of the BN-CNOs. In this study, we attached a hyaluronic acid-phospholipid (HA-DMPE) conjugate polymer to the BN-CNO’s surface to improve its hydrophilicity and provide targetability toward HA-receptor overexpressing cancer cells. To this end, various ratios of HA-DMPE to BN-CNOs were investigated. The resulting supramolecular systems were characterised via UV-Vis absorption and FTIR spectroscopy, dynamic light scattering, and zeta potential techniques. It was found that the HA-DMPE conjugate polymer was permanently wrapped around the BN-CNO nanoparticle surface. Moreover, the resulting BN-CNO/HA-DMPE supramolecular systems displayed enhanced aqueous solubility compared to unfunctionalised BN-CNOs, with excellent long-term stability observed in aqueous dispersions.
- Open Access
- 10 November 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (22) , 10565
Biocompatible Dispersants for Carbon Nanomaterials
Carbon nanomaterials (CNMs) are a fascinating class of materials that have gained considerable interest in recent years. Their favourable biocompatibility, combined with unique chemical and mechanical properties, has attracted scientists from various disciplines. A significant hurdle in their deployment in biomedical applications is their hydrophobicity in their pristine form. This review surveys and discusses existing non-covalent methods of functionalising CNMs with biocompatible dispersants to facilitate their incorporation into aqueous solutions. Different types of dispersants will be examined and compared as well as the factors affecting their efficiency. This work seeks to provide a compilation of the various methods employed in producing biocompatible CNM dispersions.
- 10 November 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (22) , 10565
Open AccessBiocompatible Dispersants for Carbon Nanomaterials
Carbon nanomaterials (CNMs) are a fascinating class of materials that have gained considerable interest in recent years. Their favourable biocompatibility, combined with unique chemical and mechanical properties, has attracted scientists from various disciplines. A significant hurdle in their deployment in biomedical applications is their hydrophobicity in their pristine form. This review surveys and discusses existing non-covalent methods of functionalising CNMs with biocompatible dispersants to facilitate their incorporation into aqueous solutions. Different types of dispersants will be examined and compared as well as the factors affecting their efficiency. This work seeks to provide a compilation of the various methods employed in producing biocompatible CNM dispersions.